Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDO2 | P48775 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | TDP2 | O95551 | 1/20 | 0.36 |
| ▸ | NSD2 | O96028 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 4/20 | 0.34 |
| ▸ | S100A4 | P26447 | 3/20 | 0.33 |
| ▸ | CDC25B | P30305 | 3/20 | 0.33 |
| ▸ | PTPRC | P08575 | 2/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4349754 | 0.73 | REN (0.35) | GAAHTTSMN1; SMN2 | |
| SCHEMBL24360032 | 0.73 | DCUN1D1 (0.50) | MEN1KMT2AGAAIDO1METAP2 | |
| SCHEMBL29908717 | 0.72 | ALDH1A1 (0.30) | SMN1; SMN2 | |
| SCHEMBL3327100 | 0.70 | KDM4E (0.49) | TDP1BLMKMT2AMETAP2KDM4E | |
| SCHEMBL3322110 | 0.70 | MGAM (0.47) | TDP1KMT2AGAAIDO1KDM4E | |
| SCHEMBL1264137 | 0.70 | DCUN1D1 (0.47) | GAATGFBR1KDM4EMAPTHTT | |
| SCHEMBL2432224 | 0.70 | KDM4E (0.57) | TDO2TDP1MEN1KMT2AGAA | |
| SCHEMBL8784700 | 0.70 | GAA (0.47) | TDP1MEN1KMT2AGAAIDO1 | |
| SCHEMBL17069012 | 0.70 | NUDT1 (0.36) | GAAHTTSMN1; SMN2 | |
| SCHEMBL535697 | 0.69 | KDM4E (0.48) | GAAKDM4ELMNACYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9082989-B2 | Platinum (II) di (2-pyrazolyl) benzene chloride analogs and uses | Arizona Board of Regents for and on behalf of Arizona State Univesity (US) | 2015-07-14 | — | — | US | disclosed |
| US-8846940-B2 | Platinum (II) di (2-pyrazolyl) benzene chloride analogs and uses | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2014-09-30 | — | — | US | disclosed |
| US-20140066628-A1 | Platinum (II) Di (2-Pyrazolyl) Benzene Chloride Analogs and Uses | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2014-03-06 | — | — | US | disclosed |
| US-20110301351-A1 | Platinum (II) Di (2-Pyrazolyl) Benzene Chloride Analogs and Uses | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-12-08 | — | — | US | disclosed |
| WO-2009086209-A2 | PLATINUM(II) DI(2-PYRAZOLYL)BENZENE CHLORIDE ANALOGS AND USES | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2009-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301351-A1 | Platinum (II) Di (2-Pyrazolyl) Benzene Chloride Analogs and Uses | PDCD1LG2, PDCD2L, IDH1 | TDO2 560/4885TDP1 3396/4885TDP2 2096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.